![Salman Al-Mahmood](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Salman Al-Mahmood
Geen lopende functies
Loopbaan van Salman Al-Mahmood
Eerdere bekende functies van Salman Al-Mahmood
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Directeur/Bestuurslid | 23-09-2010 | - |
Hoofd Techniek/Wetenschap/O&O | 23-09-2010 | - | |
Oprichter | 23-09-2010 | - |
Opleiding van Salman Al-Mahmood
Université Nancy II | Doctorate Degree |
Statistieken
Internationaal
Zwitserland | 2 |
Frankrijk | 2 |
Operationeel
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Gene Signal International SA
![]() Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Beurs
- Insiders
- Salman Al-Mahmood
- Ervaring